Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical OutcomesCatherine C. Coombs, Michael F. Berger, Ahmet Zehir et al.|Cell stem cell|2017Cited by 851
Cancer therapy shapes the fitness landscape of clonal hematopoiesisKelly L. Bolton, Dean F. Bajorin, Paul D.P. Pharoah et al.|Nature Genetics|2020Cited by 739
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision MakingWassim Abida, Howard I. Scher, Joshua Armenia et al.|JCO Precision Oncology|2017Cited by 529
Deep-Learning Model for Tumor-Type Prediction Using Targeted Clinical Genomic Sequencing DataMadison Darmofal, Quaid Morris, Shalabh Suman et al.|Cancer Discovery|2024Cited by 26
Deep Learning Model for Tumor Type Prediction using Targeted Clinical Genomic Sequencing DataMadison Darmofal, Quaid Morris, Shalabh Suman et al.|medRxiv|2023Cited by 4